Fig. 2From: A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injuryAnalysis of covariance (ANCOVA) to show the variability in the model outcomes explained by the uncertainty in the groups of probabilistic parameters in the model. The model outcomes shown are the incremental costs, incremental QALYs and incremental net monetary benefit (NMB) at a £20,000 per QALY thresholdBack to article page